USPTO serial 97041908
DEDICATYA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- O'BRIEN, JENNIFER LYNN
- Law office
- TMO LAW OFFICE 120 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with DEDICATYA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mary Frances Love
MARY FRANCES LOVE MUNCY, GEISSLER, OLDS & LOWE, P.C.4000 LEGATO ROADSUITE 310FAIRFAX, VA 22033Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical agents for the treatment of type 1 Gaucher disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceutical preparations for the treatment of type 1 Gaucher disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; pharmaceuticals for the treatment of type 1 Gaucher disease all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; veterinary preparations, namely, antioxidants; veterinary preparations, namely, pain relief medications; veterinary preparations for treatment of chronic illnesses; veterinary preparations for treatment of viral diseases; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; dietary supplements for humans and animals supplements for the treatment of type 1 Gaucher disease; supplements for the treatment of type 1 Gaucher disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; food for babies; medical dressings; plasters for medical purposes; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides; biological preparations for the treatment of type 1 Gaucher disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; chemical preparations for the treatment of type 1 Gaucher disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents for use in pharmaceuticals, drugs and medicines for the treatment of type 1 Gaucher disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; drugs for the treatment of rare diseases, in particular for the treatment of type 1 Gaucher disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; enzyme preparations for medical purposes, enzyme preparations for the treatment of type 1 Gaucher disease, medical enzyme preparations in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; enzyme preparations for veterinary purposes; medical preparations for the treatment of type 1 Gaucher disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; medicines for the treatment of type 1 Gaucher disease, all in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Medical and veterinary preparations and articles, namely, pre-filled syringes for medical purposes; Pharmaceuticals and natural remedies, for use in the treatment and management of type 1 Gaucher disease; pre-filled syringes for medical purposes; single-use pre-filled syringes; parts and fittings for all of the aforesaid goods | ACTIVE | — |
| 009 | Recorded content; Media content; Downloadable educational materials relating to type 1 Gaucher disease; downloadable support materials relating to type 1 Gaucher disease; downloadable patient support materials relating to type 1 Gaucher disease; downloadable support material relating to the treatment and management of type 1 Gaucher disease; downloadable support material relating to the use of pre-filled syringe for subcutaneous injections; downloadable computer software for use in the medical field; downloadable software for use by patients in their treatment and management of type 1 Gaucher disease; parts and fittings for all of the aforesaid goods | ACTIVE | — |
| 016 | Stationery and educational supplies; Educational equipment; Instructional and teaching material; Instructional and teaching material for patients with type 1 Gaucher disease; Instructional and teaching material for patients with type 1 Gaucher disease relating to the use of pre-filled syringe for subcutaneous injections; Printed support materials; printed support materials for patients; printed support materials for patients with type 1 Gaucher disease; printed materials to support patients with the treatment and management of type 1 Gaucher disease; instructional material relating to dosages and side effects of medications; instructional material relating to dosages and side effects of medications for type 1 Gaucher disease | ACTIVE | — |
| 035 | Advertising services; marketing services; business management; business administration services; providing office functions; advertising and marketing relating to medical and pharmaceutical goods and services; advertising and marketing relating to pharmaceuticals, medicines and supplements for the treatment of type 1 Gaucher disease; advertising and marketing relating to pharmaceuticals, medicines and supplements for the treatment of rare diseases; business information in the field of pharmaceuticals, medicines and supplements for the treatment of type 1 Gaucher disease; business information in the field of pharmaceuticals, medicines and supplements for the treatment of rare diseases; business information in the field of pharmaceuticals, medicines and supplements; providing business information; on-line wholesale store services featuring pharmaceuticals, medicines and supplements for the treatment of rare diseases; on-line wholesale store services featuring medical and pharmaceutical goods and services; on-line wholesale store services featuring pharmaceuticals, medicines and supplements for the treatment of type 1 Gaucher disease; promoting the goods and services of others via the internet in the medical and pharmaceutical industries; promoting the goods and services of others via the internet; retail pharmacy and drugstore services; retail store services featuring pharmaceuticals, medicines and supplements for the treatment of type 1 Gaucher disease; retail store services featuring pharmaceuticals, medicines and supplements for the treatment of rare diseases; retail store services featuring pharmaceuticals, medicines and supplements in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; Business assistance, management and administrative services; Clerical services; Administrative support and data processing services; Appointment reminder services; prescription reminders; appointment reminders in the medical field; prescription reminders to patients with type 1 Gaucher disease; reminders for patients to submit their prescriptions; information, advisory and consultancy services relating to the aforesaid | ACTIVE | — |
| 039 | Packaging of pharmaceuticals; storing of pharmaceuticals; shipment of pharmaceuticals; packaging of pharmaceuticals for type 1 Gaucher disease patients; storing of pharmaceuticals for type 1 Gaucher disease patients; shipment of pharmaceuticals for type 1 Gaucher disease patients; Transportation and delivery of goods; Freight and cargo transportation and removal services; Transportation of pharmaceuticals; Transportation of pharmaceuticals for type 1 Gaucher disease patients; Shipment of pre-filled syringe for subcutaneous injections; pharmacy shipments; coordinating pharmacy shipments; information, advisory and consultancy services relating to the aforesaid | ACTIVE | — |
| 041 | Publishing, reporting, and writing of texts; Publication of educational materials; non-downloadable support materials; in-home training; non-downloadable support materials for in-home training, relating to the medical field; non-downloadable support materials for in-home training for patients with type 1 Gaucher disease; Non-downloadable electronic publications; non-downloadable electronic publications for patients; non-downloadable electronic publications for type 1 Gaucher disease patients; non-downloadable support materials relating to the use and dosage of pre-filled syringe for subcutaneous injections; in-home injection training; in-home training for use of syringes for subcutaneous injections; information, advisory and consultancy services relating to the aforesaid | ACTIVE | — |
| 042 | Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software; research services; research services relating to type 1 Gaucher disease; research services relating to rare diseases; research services relating to the treatment of type 1 Gaucher disease; scientific research services; scientific research services relating to type 1 Gaucher disease; scientific research services relating to rare diseases; scientific research services relating to the treatment of type 1 Gaucher disease; laboratory research and analysis; laboratory research and analysis relating to type 1 Gaucher disease; laboratory research and analysis relating to rare diseases; laboratory research and analysis relating to the treatment of type 1 Gaucher disease; medical research services; medical research services relating to type 1 Gaucher disease; medical research services relating to rare diseases; medical research services relating to the treatment of type 1 Gaucher disease; genetic research services; genetic research services relating to type 1 Gaucher disease; genetic research services relating to rare diseases; genetic research services relating to the treatment of type 1 Gaucher disease; biological research services; biological research services relating to type 1 Gaucher disease; biological research services relating to rare diseases; biological research services relating to the treatment of type 1 Gaucher disease; clinical research services; clinical research services relating to type 1 Gaucher disease; clinical research services relating to rare diseases; clinical research services relating to the treatment of type 1 Gaucher disease; research of pharmaceuticals; platform as a service (PaaS) featuring computer software platforms for use in database management in the field of rare diseases and type 1 Gaucher disease; Software as a service (SAAS) services featuring software for database management in the field of rare diseases and type 1 Gaucher disease; hosting multimedia content for others; hosting an online website community for users to share information, photos, audio and video content and to engage in social networking; clinical trials; providing an online database comprised of patient information and medical histories for the purpose of managing and treating rare diseases and type 1 Gaucher disease; information, advisory and consultancy services relating to the aforesaid | ACTIVE | — |
| 044 | Medical services; veterinary services; hygienic and beauty care for human beings or animals; horticulture services; dispensing of pharmaceuticals, medicines and supplements for the treatment of type 1 Gaucher disease; dispensing of pharmaceuticals, medicines and supplements for the treatment of rare diseases; dispensing of pharmaceuticals, medicines and supplements; dispensing of pharmaceuticals, medicines and supplements in the form of liquids, solutions, suspensions, syrups, drops, capsules, tablets, caplets, powders, compressed tablets, dispersibiles, vapors, gases, mists, creams, gels and patches; genetic testing in relation to type 1 Gaucher disease; genetic testing in relation to rare diseases; genetic testing for medical purposes; providing healthcare and medical information in relation to type 1 Gaucher disease; providing healthcare and medical information in relation to rare diseases; providing medical product information and advisory services in relation to the treatment of type 1 Gaucher disease; providing medical product information and advisory services in relation to the treatment of rare diseases; medical, pharmacological and pharmaceutical testing services for diagnostic and treatment purposes; medical, pharmacological and pharmaceutical testing services in relation to type 1 Gaucher disease; providing pharmaceutical information and advisory services in relation to the treatment of type 1 Gaucher disease; providing pharmaceutical information and advisory services in relation to the treatment of rare diseases; providing information in relation to medical, pharmacological and pharmaceutical products for the treatment of type 1 Gaucher disease; providing information in relation to medical, pharmacological and pharmaceutical products for the treatment of rare diseases; providing news and information in the field of type 1 Gaucher disease; providing news and information in the field of medicine; providing news and information in the field of rare diseases; information, advisory and consultancy services relating to the aforesaid | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cycle Pharmaceuticals Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 016
- Other trademarks in Class 035
- Other trademarks in Class 039
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named DEDICATYA
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 18, 2022 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 18, 2022 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 18, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 31, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 31, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 31, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 17, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 25, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 27, 2021 | NWAP | NEW APPLICATION ENTERED | — |